Social media

Are your systems and processes ready for ICH GCP E6(R3)? From participant protection to technology use, these updates reshape every aspect of clinical trial processes. Our new whitepaper outlines what has changed and ho...

Sweeping updates to ICH GCP E6(R3) affect terminology, systems, participant protection and technology use. ICON experts from 45 functions decode the updates and share key impacts, risk assessments and change management...

ICON will be launching our new multiplex immunofluorescence services at Biomarkers & Precision Medicine. Come along to booth #51 to find out how our comprehensive services—from panel design to AI-powered image analysis—c...

ICON will be launching our new multiplex immunofluorescence services at Biomarkers & Precision Medicine. Come along to booth \#51 to find out how our comprehensive services—from panel design to AI-powered image analysis—...

What does true patient-centricity look like in rare disease research? In the third feature of our employee spotlight series #BehindBiotech, we share the story of Bojana Mirosavljevic - chemist, embryologist, and rare di...

What does true patient-centricity look like in rare disease research? In the third feature of our employee spotlight series #BehindBiotech, we share the story of Bojana Mirosavljevic - chemist, embryologist, and rare di...

Know where every sample is, every step of the way. LabView360 provides real-time visibility, reducing manual errors, and accelerating results. With an intuitive mobile-responsive app, sites can scan barcodes, streamline...

Know where every sample is, every step of the way. LabView360 provides real-time visibility, reducing manual errors, and accelerating results. With an intuitive mobile-responsive app, sites can scan barcodes, streamline...

The countdown is on! The 15th World Clinical Biomarkers & CDx Summit returns to Boston on 22-25 September. Visit booth #13 to connect with ICON’s biomarker and CDx specialists Sean Downing and Jin Li. From acceleratin...

The countdown is on! The 15th World Clinical Biomarkers & CDx Summit returns to Boston on 22-25 September. Visit booth \#13 to connect with ICON’s biomarker and CDx specialists Sean Downing, PhD MBA and Jin Li. From a...

It’s the final day of #DPharm, but there’s still time to connect with the ICON team at booth \#305. If you haven’t had a chance to stop by yet, we’d love to meet you and share how we’re driving innovation across clinical...

Integrating modern technologies and scientific advances into cardiovascular outcomes trials can streamline their execution and improve efficiency. Find an overview of tools and strategic approaches sponsors can use to ma...